PCRX - Pacira Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PCRX is currently covered by 10 analysts with an average price target of $36.21. This is a potential upside of $10.37 (40.13%) from yesterday's end of day stock price of $25.84.

Pacira Pharmaceuticals's activity chart (see below) currently has 272 price targets and 253 ratings on display. The stock rating distribution of PCRX is 79.59% BUY and 20.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.46% with an average time for these price targets to be met of 308.6 days.

Highest price target for PCRX is $65, Lowest price target is $17, average price target is $30.71.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 09-May-2025. First documented stock forecast 18-Jan-2013.

Currently out of the existing stock ratings of PCRX, 39 are a BUY (79.59%), 10 are a HOLD (20.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$30

$4.16 (16.10%)

$32

3 months 14 days ago
(09-May-2025)

4/21 (19.05%)

$4.88 (19.43%)

496

Buy

$65

$39.16 (151.55%)

$70

4 months 15 days ago
(08-Apr-2025)

13/29 (44.83%)

$38.73 (147.43%)

233

Hold

$18

$-7.84 (-30.34%)

$18

7 months 9 days ago
(14-Jan-2025)

1/11 (9.09%)

$-2.55 (-12.41%)

11

Hold

$17

$-8.84 (-34.21%)

$25

9 months 11 days ago
(12-Nov-2024)

4/12 (33.33%)

$0.2 (1.19%)

270

Buy

$18

$-7.84 (-30.34%)

$30

10 months 30 days ago
(24-Sep-2024)

1/4 (25%)

$3.74 (26.23%)

71

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?

On average it took 308.6 days on average for the stock forecasts to be realized with a an average price target met ratio 67.46

Which analyst has the current highest performing score on PCRX (Pacira Pharmaceuticals) with a proven track record?

LIANA MOUSSATOS

Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on PCRX

Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos with highest potential upside - $68.16

Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?

Christopher Neyor with lowest potential downside - -$15.44

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?